News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,667 Results
Type
Article (40994)
Company Profile (267)
Press Release (681396)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (204697)
Career Advice (2026)
Deals (35537)
Drug Delivery (113)
Drug Development (81393)
Employer Resources (173)
FDA (16419)
Job Trends (14949)
News (346443)
Policy (32734)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2571)
Accelerated approval (34)
Adcomms (24)
Allergies (148)
Alliances (49579)
ALS (173)
Alzheimer's disease (1679)
Antibody-drug conjugate (ADC) (319)
Approvals (16696)
Artificial intelligence (528)
Autoimmune disease (160)
Automation (43)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (194)
Biotechnology (174)
Bladder cancer (161)
Brain cancer (57)
Breast cancer (647)
Cancer (4898)
Cardiovascular disease (407)
Career advice (1711)
Career pathing (36)
CAR-T (284)
CDC (47)
Celiac Disease (2)
Cell therapy (751)
Cervical cancer (37)
Clinical research (69663)
Collaboration (1732)
Company closure (4)
Compensation (1181)
Complete response letters (57)
COVID-19 (2716)
CRISPR (93)
C-suite (868)
Cystic fibrosis (143)
Data (6352)
Decentralized trials (2)
Denatured (25)
Depression (136)
Diabetes (505)
Diagnostics (6717)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (257)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (235)
Earnings (90303)
Editorial (58)
Employer branding (21)
Employer resources (152)
Events (117556)
Executive appointments (985)
FDA (19592)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1488)
Gene editing (200)
Generative AI (44)
Gene therapy (600)
GLP-1 (972)
Government (4668)
Grass and pollen (6)
Guidances (384)
Healthcare (18885)
HIV (62)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (255)
Immuno-oncology (62)
Indications (124)
Infectious disease (2996)
Inflammatory bowel disease (195)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (256)
Interviews (316)
IPO (16644)
IRA (50)
Job creations (3645)
Job search strategy (1429)
JPM (57)
Kidney cancer (17)
Labor market (86)
Layoffs (547)
Leadership (32)
Legal (7951)
Liver cancer (92)
Longevity (16)
Lung cancer (661)
Lymphoma (382)
Machine learning (43)
Management (59)
Manufacturing (815)
MASH (165)
Medical device (13786)
Medtech (13845)
Mergers & acquisitions (19971)
Metabolic disorders (1282)
mRNA (158)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (324)
Neuropsychiatric disorders (89)
Neuroscience (2935)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4515)
Now hiring (68)
Obesity (602)
Opinion (264)
Ovarian cancer (167)
Pain (202)
Pancreatic cancer (233)
Parkinson's disease (286)
Partnered (33)
Patents (512)
Patient recruitment (501)
Peanut (59)
People (58951)
Pharmaceutical (62)
Pharmacy benefit managers (30)
Phase 1 (21716)
Phase 2 (30660)
Phase 3 (22841)
Pipeline (5564)
Policy (290)
Postmarket research (2564)
Preclinical (9205)
Press Release (64)
Prostate cancer (248)
Psychedelics (48)
Radiopharmaceuticals (284)
Rare diseases (859)
Real estate (5957)
Recruiting (70)
Regulatory (24584)
Reports (53)
Research institute (2394)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (81)
Schizophrenia (150)
Series A (244)
Series B (191)
Service/supplier (11)
Sickle cell disease (100)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3617)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (84)
The Weekly (55)
Vaccines (1013)
Venture capital (89)
Weight loss (385)
Women's health (96)
Worklife (18)
Date
Today (196)
Last 7 days (745)
Last 30 days (2555)
Last 365 days (29948)
2026 (4332)
2025 (30176)
2024 (35219)
2023 (40076)
2022 (51175)
2021 (55711)
2020 (54084)
2019 (46541)
2018 (35022)
2017 (32121)
2016 (31488)
2015 (37560)
2014 (31321)
2013 (26345)
2012 (28576)
2011 (29265)
2010 (27329)
Location
Africa (736)
Alabama (85)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (39253)
Australia (6418)
California (11485)
Canada (3329)
China (1112)
Colorado (483)
Connecticut (486)
Delaware (341)
Europe (84660)
Florida (1727)
Georgia (363)
Hawaii (3)
Idaho (61)
Illinois (878)
India (70)
Indiana (532)
Iowa (22)
Japan (438)
Kansas (127)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1403)
Massachusetts (8210)
Michigan (330)
Minnesota (631)
Mississippi (5)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (124)
New Hampshire (79)
New Jersey (3046)
New Mexico (28)
New York (3022)
North Carolina (1470)
North Dakota (8)
Northern California (5629)
Ohio (341)
Oklahoma (21)
Oregon (41)
Pennsylvania (2319)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (68)
South Dakota (1)
Southern California (4478)
Tennessee (178)
Texas (1766)
United States (40670)
Utah (345)
Vermont (1)
Virginia (267)
Washington D.C. (81)
Washington State (931)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
722,667 Results for "alphabet inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
Calico will leverage 9MW3811’s anti-inflammatory mechanism to advance its mission of addressing aging-related diseases.
June 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
February 18, 2026
·
8 min read
Business
Lilly, Novartis Sign AI Partnership with Alphabet’s Isomorphic
The multimillion-dollar collaboration will develop small molecule drugs against undisclosed targets.
January 8, 2024
·
2 min read
·
Tristan Manalac
Alphabet Soup: AACR and ACC Dominate Headlines This Week
Plus, how the geopolitical tensions with China will affect U.S. biopharma
April 9, 2024
·
1 min read
·
Greg Slabodkin, Heather McKenzie, Tyler Patchen
Press Releases
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
February 24, 2026
·
1 min read
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
February 24, 2026
·
16 min read
Press Releases
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
February 18, 2026
·
5 min read
Press Releases
Axogen, Inc. to Participate in Multiple Upcoming March 2026 Investor Conferences
February 17, 2026
·
1 min read
Press Releases
Inmar Intelligence awarded renewed Pharmacy Reverse Distribution agreement with Premier, Inc.
February 19, 2026
·
2 min read
1 of 72,267
Next
